Sentence examples for electronic container from inspiring English sources

The confidence intervals around the estimates of the effect suggest that using an electronic container did not reduce adherence but may have increased it slightly.

We used a parallel group trial design with 1 1 randomization to electronic container or standard packaging and follow up at 8 weeks (Fig.  1).

For those patients allocated to the electronic container, the nurse briefly explained its purpose and use and gave them an information sheet explaining how to use it.

Non-significantly higher adherence and lower HbA1c were observed in the electronic container group (differences in means, adjusting for baseline value: MARS, 0.4 [95 % CI −0.1 to 0.8, p = 0.11]; HbA1c (mmol/mol), −1.02 [−2.73 to 0.71, p = 0.25]).

The data from the electronic container group appeared to show a small initial increase in adherence that reduced gradually over time, which could be interpreted as being consistent with the trial results.

In the main trial analysis, both outcomes showed a difference between groups, with higher adherence and lower HbA1c in the electronic container group, but the differences were not statistically significant (p = 0.11 and p = 0.25, respectively; Table  3).

Electronic containers may lead to a small increase in adherence but this potential limitation is outweighed by their advantages.

The findings of this trial suggest that electronic containers may lead to a small increase in adherence but this potential limitation is outweighed by their advantages.

A total of 226 adults with type 2 diabetes and HbA1c ≥58 mmol/mol were randomized to receiving their main oral glucose lowering medication in electronic containers or standard packaging.

As well as reporting the trial analysis, we examined the electronic monitoring data from the group allocated to using electronic containers to look for a pattern of daily adherence over the 8-week period that might indicate an effect of electronic monitoring.

The primary clinical outcome was HbA1c at 8 weeks.> A secondary behavioral outcome measure, available only for participants in the group allocated to using electronic containers, was whether or not the correct number of doses of the main glucose lowering medication was taken as prescribed on each day over the 8-week follow-up period as measured by electronic monitoring.